<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Scott DW</submitter><funding>CCR NIH HHS</funding><funding>NCI NIH HHS</funding><funding>CIHR</funding><pagination>4949-52</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3367896</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>119(21)</volume><pubmed_abstract>Recently, the landscape of single base mutations in diffuse large B-cell lymphoma (DLBCL) was described. Here we report the discovery of a gene fusion between TBL1XR1 and TP63, the only recurrent somatic novel gene fusion identified in our analysis of transcriptome data from 96 DLBCL cases. Based on this cohort and a further 157 DLBCL cases analyzed by FISH, the incidence in de novo germinal center B cell-like (GCB) DLBCL is 5% (6 of 115). The fusion appears exclusive to GCB and was not seen in 138 non-GCB cases examined (P = .008, Fisher exact test) but was present at low incidence in follicular lymphoma (1 of 81). In all 7 cases identified, the 3' end of the fusion consists of exons 4 and onwards of TP63. The recurrence, subtype enrichment, and the remarkably conserved nature of the TP63</pubmed_abstract><journal>Blood</journal><pubmed_title>TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma.</pubmed_title><pmcid>PMC3367896</pmcid><funding_grant_id>HHSN261200800001E</funding_grant_id><funding_grant_id>P50 CA130805</funding_grant_id><funding_grant_id>HHSN261200800001C</funding_grant_id><funding_grant_id>U01 CA114778</funding_grant_id><funding_grant_id>1U01CA114778</funding_grant_id><funding_grant_id>P50CA130805-01</funding_grant_id><pubmed_authors>Tan KL</pubmed_authors><pubmed_authors>Mungall AJ</pubmed_authors><pubmed_authors>Ben-Neriah S</pubmed_authors><pubmed_authors>Connors JM</pubmed_authors><pubmed_authors>Chan FC</pubmed_authors><pubmed_authors>Mungall KL</pubmed_authors><pubmed_authors>Slack GW</pubmed_authors><pubmed_authors>Morin RD</pubmed_authors><pubmed_authors>Rogic S</pubmed_authors><pubmed_authors>Steidl C</pubmed_authors><pubmed_authors>Marra MA</pubmed_authors><pubmed_authors>Scott DW</pubmed_authors><pubmed_authors>Gascoyne RD</pubmed_authors><pubmed_authors>Lim RS</pubmed_authors></additional><is_claimable>false</is_claimable><name>TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma.</name><description>Recently, the landscape of single base mutations in diffuse large B-cell lymphoma (DLBCL) was described. Here we report the discovery of a gene fusion between TBL1XR1 and TP63, the only recurrent somatic novel gene fusion identified in our analysis of transcriptome data from 96 DLBCL cases. Based on this cohort and a further 157 DLBCL cases analyzed by FISH, the incidence in de novo germinal center B cell-like (GCB) DLBCL is 5% (6 of 115). The fusion appears exclusive to GCB and was not seen in 138 non-GCB cases examined (P = .008, Fisher exact test) but was present at low incidence in follicular lymphoma (1 of 81). In all 7 cases identified, the 3' end of the fusion consists of exons 4 and onwards of TP63. The recurrence, subtype enrichment, and the remarkably conserved nature of the TP63</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 May</publication><modification>2026-06-04T00:48:32.805Z</modification><creation>2025-08-21T09:50:39.986Z</creation></dates><accession>S-EPMC3367896</accession><cross_references><pubmed>22496164</pubmed><doi>10.1182/blood-2012-02-414441</doi></cross_references></HashMap>